Texas Health Catalyst

Accelerating the translation of research to health products

Texas Health Catalyst illustration

A program of Dell Medical School in collaboration with the Cockrell School of Engineering, College of Natural Sciences, College of Pharmacy and Office of Technology Commercialization at The University of Texas at Austin. We welcome Seton Healthcare Family as our strategic partner for the 2016-2017 Texas Health Catalyst cycle. See more about eligibility and how the program works

Texas Health Catalyst aims to:

  • Identify promising translational research that has the potential to become a value-based health product.
  • Provide timely and customized guidance on the research and development pathway from industry and clinical experts.
  • Grant seed funding for exceptional projects that may otherwise not have a source for support.

Benefits to Applicants:

Awardees can receive up to $100K to help advance their research but the benefits of the program extend far beyond the award grant.

  • All applicants receive customized feedback regarding the merits of their research project, potential roadblocks in their clinical translation plan and how to address some of these barriers.
  • During the consultation phase, applicants work closely with experienced industry experts who provide not only specific strategic, regulatory and marketing expertise, but also introductions to potential collaborators, licensing targets and sources of funding.
  • The customized guidance offered at each stage during the program can help hone clinical development strategies, improve market potential and build momentum to help to move these solutions from bench to bedside.  


Primary investigators must be:

  • UT Austin faculty members (residents and post-docs can apply as co-PIs with a UT Austin faculty PI)
  • Dell Medical School clinical affiliates
  • Seton Healthcare clinicians (residents can apply as co-PIs with a Seton clinician PI)

Projects will be scored based on the following criteria:

  • Scientific rationale
  • Clinical unmet need
  • Development feasibility
  • Potential for health impact, including commercial attractiveness to ensure path to market
  • Intellectual property status
  • New for the 2016-17 cycle: Ability to improve value of care (i.e. achieve better outcomes without increasing costs or lower costs without diminishing outcomes)

Contact us if you have any questions about eligibility including project fit, scoring criteria, industry partners and other collaborators. There may be opportunities for startups, nonprofits and other organizations to engage with the program if they align with clinical focus areas. 

▲ Collapse

How It Works

Initial Selection Process
Researchers submit brief pre-proposals for projects that target a specific health need and have the potential to translate research into a value-based therapeutic, diagnostic, device or digital health product. Following a review of pre-proposals, Texas Health Catalyst will invite select applicants to submit full applications.

Industry Guidance & Consulting Awards
Proposals are reviewed by the Texas Health Catalyst Advisory Panel, which includes Austin-area life sciences leaders and experts in fields ranging from product development and venture capital to regulatory issues and patent law. Consulting awardees are paired with members of the Advisory Panel to receive customized guidance on product development feasibility and preclinical steps. 

Financial Awards
Proposals that move past the consulting phase compete to receive awards of up to $100,000.

Award Timeline

Stage 1: Application & Review (June-September) 

  • Pre-proposals submitted (Submission Deadline: June 17, 2016 )
  • Select projects invited to submit full application (Submission Deadline: August 1, 2016)
  • Proposals reviewed by a panel of industry and clinical advisors

Stage 2: Consultation (October-November)

  • Select number of applicants granted consultation awards based on review panel scoring & feedback
  • Projects teams matched with expert industry panel members to address gaps and prepare for final report out 

Stage 3: Final Presentations, Review & Awards (December) 

  • Consulting awardees present their proposals at the report-out event (December 2016)
  • Final decisions on funding awards of up to $100,000 (direct costs)
  • Funding period: January-December 2017

Texas Health Catalyst is grateful to the Catalyst program at The University of California, San Francisco for sharing guidance and materials to help launch this program.

▲ Collapse